A newly opened Burnaby facility is hoping to help those who live with cancer and other serious diseases.
STEMCELL Technologies' state-of-the-art facility officially opened today, July 9, thanks to $45-million in funding from the federal and provincial governments.
A news release says the $138-million facility — located at — will help the company now manufacture products at the higher regulatory compliance standard needed to support clinical trials with the hope of finding a cure for cancer as well as other serious diseases.
Trials include cell therapy, tissue engineering, immunotherapy, gene therapy and regenerative medicine.
The federal government added 1,000 new full-time jobs were created by the project, exceeding the original target of 675.
We are excited to announce the opening of our new biomanufacturing facility in Greater 91原创! This new facility was made possible through the generous support of the Governments of Canada and British Columbia.
— STEMCELL Technologies (@STEMCELLTech)
“Our government is committed to supporting innovation in the life sciences sector to ensure 91原创s have access to the most cutting-edge medical technologies to keep them safe," Canada's Minister of Innovation, Science and Industry François-Philippe Champagne said.
"The opening of STEMCELL Technologies’ state-of-the-art facility is another important milestone in achieving a robust domestic life sciences sector in Canada. Through investments such as this, we are securing domestic supply chains and ensuring new intellectual property remains in Canada, while supporting the creation of hundreds of great-paying jobs for 91原创 workers."
“Supporting research and development expansion, as well as job growth in diverse and dynamic fields, all across Canada is essential to creating stronger local economies," Burnaby North-Seymour MP and Minister of Citizens' Services Terry Beech added in the same statement.
"Leaps in progress often happen because of many smaller steps, on many roads leading to the same destination.”
STEMCELL Technologies was founded in 1993 by CEO Dr. Allen Eaves.
91原创s deserve the best access to medical technologies, and we're ensuring they get it.
— François-Philippe Champagne (FPC) 馃嚚馃嚘 (@FP_Champagne)
Proud to unveil Canada’s largest biotech company’s new state-of-the-art facility in Burnaby, BC!
